CONMED CNMD Derivative Liabilities - Fair Value
Derivative Liabilities - Fair Value at other companies
Other financials
Where this comes from
Reported directly by CONMED in its filing.
Tagged under the XBRL concept us-gaap:DerivativeFairValueOfDerivativeLiability.
The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about CONMED's derivative liabilities - fair value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CONMED's derivative liabilities - fair value?
- CONMED (CNMD) reported derivative liabilities - fair value of $3.83M in Q1 2026.
- How has CONMED's derivative liabilities - fair value changed year-over-year?
- CONMED's derivative liabilities - fair value increased by 8.3% year-over-year, from $3.53M to $3.83M.
- What is the long-term trend for CONMED's derivative liabilities - fair value?
- Over 5 years (2020 to 2025), CONMED's derivative liabilities - fair value has grown at a -9.0% compound annual growth rate (CAGR), from $9.51M to $5.94M.
- What does derivative liabilities - fair value mean?
- This metric represents the total fair market value of all derivative contracts currently in a liability position for the institution. It reflects the potential cash outflow required if these contracts were settled at the current reporting date. Monitoring this value is essential for assessing the bank's exposure to market volatility and counterparty risk.